Your partner in science for end-to-end CRDMO solutions
Business Transformation during a Pandemic: Q&A about Jubilant Biosys’ bold plans with Marcel J. Velterop, President
A discussion with Hassan Pajouhesh, Ph.D., Director of Medicinal Chemistry at SiteOne Therapeutics.
A discussion with Bob Volkmann, Ph.D., Founder and Chief Scientific Officer of BioPharmaWorks.
A discussion with Siegfried Reich, Ph.D., Co-Founder and Senior Vice President, Research, at eFFECTOR Therapeutics.
A discussion with Michael Gallatin, Ph.D., President and Co-Founder of Mavupharma (Mavu).
